Aims Anti-tachycardia pacing (ATP) is a reliable electrotherapy to painlessly terminate
ventricular tachycardia (VT). However, ATP is often ineffective, particularly for fast VTs. The …

Introduction Antitachycardia pacing (ATP) is used to terminate ventricular tachycardia (VT)
by delivering rapid, low energy pacing to the right ventricle (RV). Unfortunately, ATP is not …

The implanted cardioverter defibrillator (ICD) is an effective direct therapy for the treatment of
cardiac arrhythmias, including ventricular tachycardia (VT). Anti-tachycardia pacing (ATP) is …

Background Antitachycardia pacing (ATP) success rates as low as 50% for fast ventricular
tachycardias (VTs) have been reported providing an opportunity for improved ATP to …

Introduction: ICDs often are programmed with antitachycardia pacing (ATP) as the first
response to ventricular tachycardia (VT). Many ICDs have an additional lead available for …

Purpose Antitachycardia pacing (ATP) terminates the majority (but not all) of slow ventricular
tachycardias (S-VT) with a cycle length (CL)> 320 ms. Usually, several ATP therapies are …

This editorial refers to 'Safety and efficacy of programming a high number of antitachycardia
pacing attempts for fast ventricular tachycardia: a prospective study'by RP Martins et al., on …

Background Antitachycardia pacing (ATP) is a programmable therapy in implantable cardiac
defibrillator (ICD) devices that has been demonstrated to effectively reduce the need for …

Intrinsic anti-tachycardia pacing (iATP) is a novel automated ATP algorithm that employs
post-pacing interval (PPI) to design the next ATP sequence based on an analysis of the prior …

We report the usefulness of novel automated anti-tachycardia pacing (ATP) for ventricular
tachycardia (VT) termination evaluated in an electrophysiology study. This intrinsic …